Mustang Bio Inc (MBIO)

NASDAQ
0.469
0.000(0.09%)
After Hours
0.480
+0.011(+2.258%)
- Real-time Data
  • Volume:
    207,463
  • Day's Range:
    0.460 - 0.488
  • 52 wk Range:
    0.415 - 2.650

MBIO Overview

Prev. Close
0.469
Day's Range
0.46-0.488
Revenue
-
Open
0.46
52 wk Range
0.415-2.65
EPS
-0.79
Volume
207,463
Market Cap
49.72M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
581,196
P/E Ratio
-0.711
Beta
1.58
1-Year Change
-82.55%
Shares Outstanding
105,915,111
Next Earnings Date
Nov 15, 2022
What is your sentiment on Mustang Bio?
or
Market is currently closed. Voting is open during market hours.

Mustang Bio Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Mustang Bio Inc Company Profile

Mustang Bio Inc Company Profile

Employees
62

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that is focused on translating medical breakthroughs in cell and gene therapies into cures for hematologic cancers, solid tumors and rare genetic diseases. The Company's pipeline is focused on three core areas: gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Its products include MB-107 and MB-207 is an Ex vivo Lentiviral Therapy for X-linked Severe Combined Immunodeficiency (XSCID). XSCID is a rare genetic immune system condition also known as bubble boy disease. It is developing CAR T therapies for hematologic malignancies in partnership with COH targeting CD123 (MB-102) and CS1 (MB-104) and with Fred Hutch targeting CD20 (MB-106). The Company is also developing CAR T therapies for solid tumors in partnership with COH targeting IL13Ra2 (MB-101), HER2 (MB-103) and PSCA (MB-105).

Read More

Analyst Price Target

Average7.200 (+1435.18% Upside)
High8
Low5
Price0.469
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • any news on results
    0
    • when should they be posted?
      0
  • within 2 day will hit to $4.50
    4
    • We wish
      0
  • Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency 
    0
    • GO DOWNN!! I WANT INNN
      0
      • Underated
        0
        • Get down to $3.65, let me in
          0
          • U naughty
            0
            • A Horse from Hell! Well, death don’t hurt very long!
              0
              • Okay, go ahead, Better Be Better!
                0
                • Received a letter from Colonel Forbin, he is way ahead, near a shore up against the jagged rocks, though he’s trip was not short he has another vacation coming but he knows he just can’t go. He left us Thread we can follow...see that Long Fuse hidden by that line of Cactus?...that’s our path, come on, Better, we need a Taste 4 Free!
                  0